Tag: CMS
Eisai, Biogen Alzheimer’s disease drug could be available to some as early as next year
Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with...